While it has been found to be a ligand for CD1d, is also included within the lipid network promoted by mTORC2, and is slightly elevated by SK1 knockdown (data not shown), there is not much evidence for or against its role as an NKT cell antigen in cancer (56, 67). The gene discussed is CD1D; the disease is cancer.